• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

BREAKING: One-Year Delay on ICD-10 to October 2014 Finalized

Article

The federal government has finalized a one-year delay in the compliance deadline for the nationwide conversion to ICD-10 code sets. The delay, first proposed in April, will move the compliance deadline to Oct. 1, 2014.

Read the full story: http://tinyurl.com/9al4xja

Source: ModernHealthcare.com

HHS said the extra time would allow healthcare organizations—small organizations in particular—adequate time to get ready for the changeover.

Related Videos
4 experts in this video
4 experts in this video
Rakendu Rajendran, MBBS
Vivek Bhalla, MD, Stanford University School of Medicine
Dr Carla Nester
Rayan Salih, MD, Northeast Georgia Health System
Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI, Mount Sinai Fuster Heart Hospital
AJMC interview with Ali Shan Hafeez and Dr Abdul Rafae Faisal | Background image credit: ipopba - stock.adobe.com
Related Content
Hospital staff stocktaking in pharmacy | Image credit: Jacob Lund - stock.adobe.com

How Hospital Pharmacies Are Tackling Rising Drug Costs

August 6th 2025
Article

A new report from Bluesight reveals how automation and analytics are helping hospital pharmacy teams cut spending, manage shortages, and streamline procurement.

Read More

AJMC podcast banner

What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD

August 5th 2025
Podcast

Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.

Listen

Dordaviprone is indicated for recurrent H3 K27M-mutant diffuse midline glioma, an ultra-rare, aggressive brain tumor primarily affecting children. | Image credit: wladimir1804 - stock.adobe.com

FDA Approves Dordaviprone as First and Only Treatment for Aggressive Form of Glioma

August 6th 2025
Article

Dordaviprone (Modeyso) is now approved to treat recurrent H3 K27M-mutant diffuse midline glioma, an ultra-rare, aggressive brain tumor primarily affecting children.

Read More

The Center for Biosimilars podcast banner

Follow the Science: Bridging the Biosimilar Gap With Dr Hillel Cohen

July 29th 2025
Podcast

Listen

RSV, COVID, Flu vaccines. | Image credit: angellodeco - stock.adobe.com

RFK Jr Axes $500 Million in Funding for mRNA Vaccine Development

August 6th 2025
Article

Robert F. Kennedy Jr halted 22 mRNA vaccine initiatives, drawing criticism from health experts over pandemic preparedness concerns.

Read More

myasthenia gravis | Image Credit: © Maggie-sora.chatgpt.com

Unique Psychological Burden of Fear of Progression Seen in MG

August 6th 2025
Article

Fear of progression is common among patients living with chronic diseases, but the degree to which it interferes with patient outcomes, including treatment adherence, deserves further investigation, study authors note.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.